Prophylactic Mastectomy Alternative
Prophylactic Mastectomy Alternative - Related Videos
02:21
Radical Mastectomy: Surgical Removal of the Entire Mammary Gland from a Mouse to Study Cancer Progression
0 Views •
2023
This video describes a technique of radical mastectomy, which is used for the surgical removal of the entire mammary gland from a mouse to study cancer progression.
06:42
Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
0 Views •
2025
This article presents a detailed protocol for collecting breast cancer samples, designed to optimize their utility for biobanking, personalized medicine, and other research applications. The workflow for sample collection, including breast biopsy and mastectomy procedures, is described in detail, focusing on minimizing tissue damage and maximizing sample quality.
02:18
Alternative RNA Splicing
0 Views •
2020
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity. There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
09:11
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
0 Views •
Cited by 35 •
2016
Zika Virus (ZIKV), an emerging pathogen, is linked to fetal developmental abnormalities and microcephaly. The establishment of an effective infectious cell culture system is crucial for studies of ZIKV replication as well as vaccine and drug development. In this study, various virological assays pertaining to ZIKV are illustrated and discussed.
01:16
Null and Alternative Hypotheses
0 Views •
2023
The actual hypothesis testing begins by considering two hypotheses. They are termed the null hypothesis and the alternative hypothesis. These hypotheses contain opposing viewpoints. The null hypothesis, denoted by H0 is a statement of no difference between the variables—they are not related. This can often be considered the status quo. As a result if you cannot accept the null, it requires some action. The alternative hypothesis, denoted by H1 or Ha, is a claim about the population that is...
FAQs
Risk management relies on different mechanisms rather than one intervention. Enhanced surveillance seeks to identify changes through mammography and magnetic resonance imaging, while risk-reducing medications interfere with hormone-driven tumor development. Genetic counseling adds information about inherited susceptibility and family history, allowing prevention planning to reflect a person’s risk profile instead of applying the same strategy to everyone.
These imaging approaches provide the monitoring component of a non-surgical prevention strategy. Using both mammography and magnetic resonance imaging supports closer observation of people whose inherited susceptibility or family history indicates elevated concern. The resulting surveillance information can be considered alongside genetic findings and personal risk when evaluating whether continued monitoring or another risk-management approach is appropriate.
Risk-reducing medications work by interfering with hormone-driven tumor development, addressing a biological pathway associated with some breast cancers. They therefore differ from imaging, which monitors for changes, and from surgery, which removes tissue. In prevention research, medication-based approaches can be evaluated by comparing cancer incidence, treatment outcomes, and quality-of-life effects with other strategies.
Genetic counseling helps place inherited susceptibility and family history into the prevention decision. Its information can guide discussion of enhanced surveillance, risk-reducing medication, or preventive surgery while recognizing that risk management is individualized. In cancer research, genetic findings also help investigators compare outcomes across groups with different underlying risk profiles and prevention choices.
The process begins by considering inherited susceptibility, family history, genetic findings, and personal risk. Clinicians and patients can then weigh enhanced surveillance, magnetic resonance imaging and mammography, risk-reducing medication, or preventive surgery. Comparing expected cancer incidence, treatment outcomes, quality of life, and surgical risks helps connect the selected approach with the person’s priorities and circumstances.
Researchers compare these approaches using outcomes that extend beyond whether cancer develops. Studies may examine cancer incidence, treatment outcomes, quality of life, and the risks associated with surgery, alongside the effects of ongoing monitoring or medical prevention. This evidence supports individualized comparisons between preventive surgery and non-surgical strategies for people with elevated risk.